|
|
||||||||
Journal of Physiology (2001), 536.2, pp. 615-623
© Copyright 2001 The Physiological Society
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Skin sympathetic nerve activity (SSNA) contains neural signals of sudomotor and vasomotor origins (Vallbo et al. 1979; Janig & Kummel, 1981). A number of factors (e.g. mental stress, exercise and hyperventilation) alter SSNA (Delius et al. 1972b; Hagbarth et al. 1972). SSNA is also very responsive to changes in internal as well as skin temperatures (Bini et al. 1980; Vissing, 2000). Cooling presumably increases the vasoconstrictor component of the SSNA signal, while thermoneutral conditions or slight heating withdraws this activity. Upon more pronounced heating, SSNA increases dramatically, which is thought to be the neural signal responsible for increasing sudomotor and/or cutaneous active vasodilator activities.
The effects of baroreceptor loading/unloading on SSNA do not consistently agree with published reports of baroreceptor modulation of skin blood flow. In normothermic individuals, direct stimulation of the carotid sinus nerve (Wallin et al. 1975), Valsalva manoeuvres (Delius et al. 1972b), lower-body negative pressure (LBNP; Vissing et al. 1994), or spontaneous variations in blood pressure (Hagbarth et al. 1972) fail to alter SSNA. These data suggest that the vasoconstrictor limb of SSNA is not altered by baroreflexes in normothermia. These findings are perplexing given data from our and others' laboratories demonstrating that baroreceptor unloading in normothermic subjects decreases cutaneous vascular conductance (Johnson et al. 1973; Rowell et al. 1973; Tripathi & Nadel, 1986; Kellogg et al. 1990; Crandall et al. 1996). Given that sudomotor, pilomotor and active vasodilator activity is presumably absent in the SSNA recording when the individual is in normothermia (in the absence of arousal stimuli) coupled with the aforementioned lack of change in SSNA during baroreceptor perturbations in normothermic individuals, the neural signal leading to decreases in cutaneous vascular conductance during baroreceptor unloading remains unknown.
Whole-body heating causes pronounced increases in SSNA. It is presumed that this increase in SSNA leads to increases in sweating and/or skin blood flow (Hagbarth et al. 1972; Normell & Wallin, 1974). The effects of baroreceptor loading/unloading on SSNA in heated individuals are not clear. Dodt et al. (1995) reported that SSNA decreases in mildly heated individuals during baroreceptor unloading with LBNP and with head-up tilt, and others have reported that SSNA displays cardiac rhythmicity (Bini et al. 1981; Macefield & Wallin, 1996). Taken together, these studies imply that baroreceptors are capable of modulating SSNA. In contrast, Vissing et al. (1994) suggested that decreases in SSNA during LBNP in mildly heated individuals were due to skin-surface cooling associated with LBNP and not due to baroreceptor unloading. These conflicting findings are further clouded by observations that baroreceptor unloading in heated subjects have been reported to decrease cutaneous vascular conductance via withdrawal of cutaneous active vasodilatation (Kellogg et al. 1990; Crandall et al. 1996), decrease sweat rate (Mack et al. 1995), as well as decrease the slope relating the elevation of sweat rate to the elevation in internal temperature (Solack et al. 1985). Taken together, the effects of baroreflex modulation of SSNA, and accompanying end-organ responses, in normothermic and heat-stressed individuals remain an open question.
A limitation of the aforementioned studies is the potentially confounding effects of non-baroreflex-mediated responses (e.g. emotional responses or skin-surface cooling) affecting SSNA during the perturbation used to change blood pressure. An alternative method of baroreceptor loading/unloading is the use of pharmacological agents to decrease and increase blood pressure. This method alters arterial blood pressure without causing skin-surface cooling or emotional responses that may accompany other methods of baroreceptor loading/unloading such as LBNP. Prior investigations have used these methods to assess baroreflex control of muscle sympathetic nerve activity under a variety of conditions (Rudas et al. 1999). To the authors' knowledge no study has combined the effects of whole-body heating with pharmacologically induced arterial baroreceptor modulation with a goal of investigating baroreflex control of SSNA and sweating. Such a study may be beneficial in furthering an understanding of baroreflex control of SSNA and sweat rate in heat-stressed individuals. Therefore, the purpose of this project was to test the hypothesis that arterial baroreflexes modulate SSNA and sweat rate during pharmacological manipulations of blood pressure in normothermic and heat-stressed humans.
| METHODS |
|---|
|
|
|---|
Subjects
Seven healthy subjects (3 men, 4 women) participated in the project. The participants' mean age was 27.7 ± 2.1 years and all were of typical height (174.5 ± 2.7 cm), weight (69.9 ± 2.4 kg), and body surface area (1.40 ± 0.1 m2; Du Bois & Du Bois, 1916). Written informed consent was obtained from all participants prior to enrolling in this study. The protocol and informed consent received institutional approval and the study conformed to the Declaration of Helsinki.
Measurements
Multiunit postganglionic SSNA was recorded from the common peroneal nerve. After mapping the nerve pathway via external stimulation, an uninsulated reference electrode was inserted 2-3 cm from the projected insertion site of the recording electrode. A second recording electrode, with a tip diameter between 1 and 5 µm, was inserted into the peroneal nerve dorsal to the fibular head. The signal was amplified
1000 and passed through a band-pass filter (700-2000 Hz) with a gain between 60 and 90 (Iowa Bioengineering, Iowa City, IA, USA). The filtered neurogram was then rectified and integrated to obtain a mean voltage display. This signal was sampled at 200 Hz via a computer data acquisition system (Biopac Systems, Santa Barbara, CA, USA). Identification of SSNA was determined following standard guidelines previously published (Delius et al. 1972a,b). Total activity of multiunit skin sympathetic nerves was obtained with the aid of data analysis software post hoc (Acknowledge, Biopac Systems). Heart rate was obtained from an electrocardiogram (SpaceLabs, Redmond, WA, USA) with the signal interfaced with a cardiotachometer (CWE, Ardmore, PA, USA). Arterial blood pressure was obtained on a beat-by-beat basis via a tonometric blood pressure system (Collins, San Antonio, TX, USA). Local skin blood flow was measured via laser-Doppler flowmetry using integrating flow probes (Perimed, North Rayalton, OH, USA) attached to the dorsal portion of the foot within the area of peroneal nerve innervation. Cutaneous vascular conductance (CVC) was indexed by dividing laser-Doppler flux values by mean arterial blood pressure (MAP) and multiplying that number by 100. Sweat rate was measured via capacitance hygrometry (Viasala, Woburn, MA, USA) by perfusing 100 % nitrogen at a flow rate of 300 ml min-1 through a ventilated capsule (surface area = 2.83 cm2) attached to the skin also within the area of innervation of the nerve fascicle being recorded. Internal temperature (Tsl) was indexed from a thermocouple placed in the sublingual sulcus. Mean skin temperature (Tsk) was measured via the weighted average of six thermocouples attached to the skin (Taylor et al. 1989).
Protocols
The protocol consisted of performing the outlined procedures first under normothermic conditions, followed by repeating the procedures after whole-body heating. Whole-body heating was performed via perfusing 46 °C water through a tube-lined suit worn by each subject (Carleton Technologies, Tampa Bay, FL, USA). This method of heating typically increases skin temperature to ~38 °C and Tsl 0.6-1.0 °C after 30-60 min of heating. In the present protocol water temperature perfusing the suit was slightly reduced to 44-45 °C 10-15 min prior to drug infusion in an attempt to cause Tsl to plateau during the ensuing baroreceptor perturbations.
Bolus injections of nitroprusside and phenylephrine
In both thermal conditions blood pressure was first decreased then increased via bolus infusions of 100 µg sodium nitroprusside followed by 150 µg phenylephrine, respectively. Care was taken to avoid arousing the subject during drug infusion. This was accomplished by having the subject close his/her eyes 30-60 s prior to intravenous drug administration, and by the investigators using visual cues to communicate the onset of drug delivery. Thus, the subject was unaware of the onset of drug delivery thereby minimizing any anticipatory response associated with drug delivery. Bolus phenylephrine infusion began approximately 60 s after the onset of the nitroprusside infusion. In each thermal condition three of these challenges were performed, with the responses within each thermal condition averaged. This method of pharmacological manipulation of blood pressure to assess baroreflex control of muscle sympathetic nerve activity and heart rate has been described previously (Ebert & Cowley, 1992; Rudas et al. 1999).
Steady-state infusions of sodium nitroprusside
In a separate protocol, four subjects received steady-state intravenous infusions of sodium nitroprusside that were administered over 8-10 min in both the normothermic and heat-stress conditions. Doses of nitroprusside (20-100 µg min-1) were sequentially infused via a constant infusion pump through the venous catheter. This method of sodium nitroprusside administration causes sustained decreases in MAP leading to baroreflex-mediated increases in heart rate over the duration of the infusion (Birkett et al. 1992).
Data analysis
Data were continuously acquired throughout normothermic and heat-stress procedures. For the bolus procedure, data were averaged into the following 20 s blocks: immediately prior to nitroprusside infusion, immediately prior to phenylephrine infusion, and 10 s prior to and after the highest stable blood pressure achieved with phenylephrine infusion, which typically occurred between 40 and 60 s after phenylephrine administration. Data analysis was limited to 20 s periods due to the method used to alter blood pressure (i.e. sequential bolus infusions) in combination with the short action of the drugs. The goal of this method of data analysis was to obtain data when blood pressure was at its lowest point during nitroprusside infusion and at its highest point during phenylephrine infusion. For the steady-state protocol, data were averaged from the minute immediately prior to the onset of drug delivery and from the last minute of each dose of nitroprusside. For both thermal conditions, SSNA was normalized based upon the 20 s period (for bolus protocol) and the 1 min period (for steady-state protocol) immediately prior to each drug infusion. This method of analysis eliminates potential errors associated with subtle changes in electrode position that may occur over long duration SSNA recordings.
In each thermal condition, data (i.e. heart rate, MAP, sweat rate and SSNA) were analysed via one-way repeated analysis of variance to identify differences between pre-drug, sodium nitroprusside and phenylephrine phases. Assessment of the effects of whole-body heating on temperature and haemodynamic responses was undertaken with Student's paired t test. No direct statistical comparisons were performed for SSNA between normothermic and heat-stress conditions due to subtle shifts in the electrode during the course of whole-body heating requiring repositioning of the electrode for some subjects. Skin blood flow was not analysed during the drug perturbations due to the confounding effects of the drug acting directly on the cutaneous vasculature independent of neural control. All values are reported as means ± S.E.M. The
-level for all statistical analyses was set at 0.05.
| RESULTS |
|---|
|
|
|---|
Temperature and cardiovascular variables
Whole-body heating increased Tsk to 37.9 ± 0.3 °C, while Tsl increased approximately 0.6 °C and CVC increased more than 6-fold when compared to normothermia (see Table 1). Cardiovascular variables in normothermic and heat-stress conditions are listed in Table 1. Baseline MAP was maintained during the heat stress while heart rate increased significantly when compared to normothermia. In normothermia, baseline MAP was 76 ± 2 mmHg, and decreased with bolus sodium nitroprusside to 65 ± 2 mmHg (P < 0.05), followed by an increase to 79 ± 2 mmHg (P < 0.05 from baseline) with infusion of phenylephrine (see Table 2). Comparable MAP values were obtained during hyperthermia (baseline: 76 ± 2 mmHg; nitroprusside: 69 ± 3 mmHg (P < 0.05 from baseline); phenylephrine: 82 ± 2 mmHg (P < 0.05 from baseline)). Prior to drug administration, heart rate was 55 ± 3 and 74 ± 3 beats min-1 for normothermic and heat-stress conditions, respectively. Sodium nitroprusside infusion resulted in an increase in heart rate to 72 ± 4 and 92 ± 4 beats min-1 (both P < 0.05 from respective baselines), while phenylephrine infusion resulted in a decrease in heart rate to 51 ± 3 and 68 ± 4 beats min-1 (both P > 0.05 from respective baselines) for normothermic and heat-stress conditions, respectively.


Steady-state infusion of nitroprusside at the highest dose received by all subjects (60 µg min-1) significantly decreased MAP in both thermal conditions (normothermia: from 76 ± 3 to 68 ± 2 mmHg; heat stress: from 75 ± 1 to 63 ± 1 mmHg; both P < 0.05), resulting in baroreflex-mediated increases in heart rate (normothermia: from 61 ± 2 to 83 ± 5 beats min-1; heat stress: from 85 ± 4 to 103 ± 5 beats min-1; both P < 0.05; see Table 3).

Sweat rate and SSNA
SSNA was not significantly altered during decreases or increases in arterial blood pressure via bolus infusions, regardless of the thermal status (see Fig. 1). As MAP was reduced, SSNA did not decrease; if anything there was a small, but statistically insignificant, increase in skin nerve traffic in both thermal conditions (see Fig. 1). An example of the time course of pharmacologically induced changes in MAP, heart rate and subsequent lack of an effect on SSNA can be seen in Fig. 2A for normothermia and in Fig. 2B for heat-stress conditions. The subject in Fig. 2 clearly increased SSNA in the heat-stress condition when compared to normothermia. The pronounced elevation in SSNA that occurred during the heat stress rapidly decreased during cooling following the end of the heat stress (see Fig. 3).
![]() |
View larger version [in this window] [in a new window] |
|
|
Figure 1. Effects of baroreceptor modulation via bolus sodium nitroprusside (NP) and phenylephrine (PE) administration on mean arterial blood pressure (MAP) and normalized skin sympathetic nerve activity (SSNA) during both normothermia and hyperthermia Baseline (Base) prior to each thermal condition was used for normalization (i.e. 100 %). Regardless of the thermal conditions, SSNA was unaffected by baroreceptor unloading or loading. Values are expressed as means ± S.E.M. | ||
![]() |
View larger version [in this window] [in a new window] |
|
|
Figure 2 Representative data from one subject during bolus sodium nitroprusside (NP) and phenylephrine (PE) infusions on skin sympathetic nerve activity (SSNA), heart rate (HR), and arterial blood pressure (BP) during normothermia (A) and during heat stress (B). | ||
![]() |
View larger version [in this window] [in a new window] |
|
|
Figure 3 Representative data from one subject during whole-body cooling after the heat stress on mean skin temperature (Tsk), skin sympathetic nerve activity (SSNA), skin blood flow (SkBF) and sweat rate (SR). Sublingual temperature was not altered during the period represented by this figure. | ||
For the bolus infusion protocol, sweat rate increased to a mean value of 0.69 ± 0.12 mg cm-2 min-1 prior to drug administration during the heat stress. Decreases in MAP with bolus injections of sodium nitroprusside did not significantly reduce sweat rate. In contrast, there was a small, but statistically significant, increase in sweat rate when MAP was reduced (see Table 2). This increase in sweat rate persisted during phenylephrine infusion, but no differences in sweat rate were identified between the nitroprusside and phenylephrine conditions. We do not believe this small increase in sweat rate was due to unloading or loading of arterial baroreceptors. Rather, we believe that this slight increase in sweat rate was due to small, progressive and statistically significant increases in Tsl (0.03 °C) during the period in which drugs were administered, despite attempts to cause Tsl to plateau prior to drug administration. Nevertheless, sweat rate did not decrease when MAP was reduced as would be expected if sweat rate was modulated by baroreceptors.
Similar to that observed during the bolus infusion protocol, sustained reductions in arterial blood pressure over 8-10 min via steady-state infusions of sodium nitroprusside also did not elicit significant changes in SSNA or sweat rate regardless of the thermal condition (see Table 3).
| DISCUSSION |
|---|
|
|
|---|
The major findings of the present study are that arterial blood pressure modulation, caused by bolus sodium nitroprusside and phenylephrine infusions, as well as by steady-state nitroprusside infusions, failed to alter either SSNA or sweat rate. This observation was consistent in both normothermic and heat-stress conditions. These data provide evidence demonstrating that SSNA and sweating may not be modulated by arterial baroreceptors even when SSNA and sweating rate are elevated during whole-body heating. The unique aspects of this study include the method of blood pressure modulation, the degree of heat stress, and simultaneous recording of both SSNA and end-organ responses (e.g. sweat rate) during blood pressure challenges.
Whole-body heating did not alter baseline MAP (see Tables 1 and 3). Prior studies indicate that whole-body heating decreases central venous pressure by 3-5 mmHg (Rowell, 1983; Crandall et al. 1999). Maintenance of MAP, despite decreases in central venous pressure, is accomplished by increasing cardiac output and by altering regional vascular resistances (Johnson & Proppe, 1996). In the present study, baseline heart rate increased ~19 beats min-1 and cutaneous vascular conductance increased over 6-fold with the heat stress (see Table 1).
Bolus injections of sodium nitroprusside decreased blood pressure while phenylephrine increased blood pressure from the nitroprusside nadir. In all cases phenylephrine either returned blood pressure to pre-drug levels or increased it 3-4 mmHg above this level. Changes in arterial blood pressure as a result of these drugs were similar in both thermal conditions. However, the magnitude of reduction in arterial blood pressure during the heat stress with sodium nitroprusside was slightly less than that observed in normothermia (see Fig. 1). In prior studies, sodium nitroprusside and phenylephrine bolus injections with identical doses resulted in slightly greater changes in blood pressure than that seen in this study (Ebert & Cowley, 1992). Even though arterial blood pressure was not altered to the same extent as in previous work, we are confident that blood pressure changed sufficiently to evoke baroreflex-mediated responses given the observed change in heart rate (see Fig. 2 and Tables 2 and 3).
We hypothesized that baroreceptor modulation, as previously shown by Mack et al. (1995), would decrease sweat rate during the heat stress in an effort to preserve hydration status. This, however, was not observed in the present study, as sweat rates were not altered despite rapid and sustained reductions in MAP induced with sodium nitroprusside. However, three important distinctions should be raised between the present investigation and previous studies with respect to sweat rate and baroreceptor unloading. First, we used water-perfused suits to increase internal temperature while Mack et al. (1995) used dynamic exercise in a moderately warm room to heat the subjects. Thus, differing stimuli to increase internal temperature or exercise itself may result in conflicting findings. Secondly, Mack et al. (1995) and Solack et al. (1985) used LBNP to unload baroreceptors, which may cause skin-surface cooling and potentially confound the interpretation of the results (Vissing et al. 1994). Skin-surface cooling can cause abrupt and dramatic decreases in SSNA, skin blood flow and sweat rate in heated individuals even before marked changes in internal or mean skin temperatures are identified (see Fig. 3). Third, the present study assessed sweat rate from non-glabrous skin on the dorsal aspect of the foot, which might exhibit different control of sweat rate relative to the chest and forearm which were assessed in the cited studies.
Pharmacological modulation of MAP did not change SSNA in either thermal condition. This finding is in agreement with some, but not all, previous research. In normothermic individuals direct stimulation of the carotid sinus nerve (Wallin et al. 1975), Valsalva manoeuvres (Delius et al. 1972b), LBNP (Vissing et al. 1994), or spontaneous variations in blood pressure (Hagbarth et al. 1972) fail to alter SSNA. However, less clear are conclusions regarding the effects of blood pressure modulation of SSNA in individuals with elevated SSNA due to heat stress. To investigate this question Macefield & Wallin (1996) measured single sudomotor axon discharge in moderately heated individuals during spontaneous fluctuations in blood pressure. They identified that some of these axons showed weak, but significant, correlation with spontaneous fluctuations in cardiac interval and in diastolic blood pressure. These findings are similar in concept to findings by Dodt et al. (1995), which observed decreases in SSNA in mildly heated subjects during LBNP and during head-up tilt. In contrast, Vissing et al. (1994) did not see changes in SSNA during LBNP in mildly heated individuals when skin-surface cooling, which occurred during the application of LBNP, was controlled. Differences between these studies may be related to the method of heating, the magnitude of heating, the baroreceptor populations perturbed and/or the technique used to perturb the baroreceptors. The advantage of the present study is that relatively large decreases in MAP were accomplished in passively heated individuals without the potentially confounding influences of skin-surface cooling.
Another important difference between the present study and prior studies may be the relative difference in the unloading of specific baroreceptor populations. Both LBNP and upright tilt are likely to cause relatively greater unloading of the cardiopulmonary baroreceptors when compared to unloading of the arterial baroreceptors (i.e. carotid and aortic baroreceptors). In contrast, it is likely that with the present technique the arterial baroreceptors were unloaded to a greater relative extent than the cardiopulmonary baroreceptors given findings by Dibner-Dunlap et al. (1996) that central venous pressure does not change during bolus infusions of sodium nitroprusside and phenylephrine in healthy subjects. Previously, we and others were unable to demonstrate that carotid baroreceptor perturbations caused changes in cutaneous vascular conductance (Crandall et al. 1996) or SSNA (Wallin et al. 1975). Given these findings, a reasonable hypothesis would be that the lack of change in SSNA and sweat rate observed in the present study was due to the perturbation primarily unloading baroreceptor populations (i.e. carotid and aortic) that may not have an efferent limb governing SSNA or sweat rate. In contrast, changes in SSNA during head-up tilt or LBNP observed by others may be due solely to cardiopulmonary baroreceptor unloading (Dodt et al. 1995, Mack et al. 1995). Thus, differing responses between the present study and those previously reported may be due to the method of baroreceptor unloading.
The present study suggests that rapid and steady-state changes in arterial blood pressure do not modulate integrated multiunit SSNA. However, this finding is in contrast to prior work by Macefield & Wallin (1996) in which some single unit recordings of sudomotor SSNA showed a weak correlation with diastolic pressure and cardiac interval in heated individuals. These authors suggested that single unit recordings of sudomotor SSNA may be influenced by arterial baroreceptors. Differences in conclusions between the cited study and the present study are not clear, but may be related to differences in firing/recording of single unit neurons during baroreceptor loading/unloading as opposed to recording integrated responses from multiunit SSNA.
Limitations to the interpretation of the results
Upon completion of the bolus infusion protocol we could not exclude the possibility that the absence of a change in sweat rate in response to brief periods of baroreceptor unloading (i.e. bolus infusion) was due to the time period in which MAP was reduced relative to the potentially longer time course that may be necessary to observe a change in sweat rate following a change in blood pressure. However, the validity of this argument may be questioned given the lack of change in SSNA during these changes in blood pressure, which would not be expected to exhibit a similar delay if SSNA was modulated by baroreceptors. Nevertheless, to address this issue, in a separate protocol blood pressure was progressively reduced over a period of 8-10 min via steady-state infusions of sodium nitroprusside. Despite appropriate and sustained decreases in blood pressure, coupled with baroreflex-mediated increases in heart rate (see Table 3), no change in SSNA or sweat rate was observed in any subject regardless of the thermal conditions. Thus, it is unlikely that a lack of arterial baroreflex modulation of SSNA or sweat rate was due to the brief period in which arterial blood pressure was altered during the bolus infusion protocol.
Another potential limitation of the present study could be related to the magnitude of change in arterial blood pressure during bolus and steady-state infusions. With the present data we cannot exclude the possibility that the degree of arterial blood pressure modulation might have been insufficient to evoke a response in SSNA and/or sweat rate. However, this possibility is unlikely given the relatively large change in heart rate observed during drug administration (see Fig. 2 and Tables 2 and 3), which clearly indicates the baroreflexes were unloaded/ loaded (Mancia & Mark, 1983).
In conclusion, pharmacological modulation of arterial blood pressure with sodium nitroprusside and phenylephrine did not change SSNA in either normothermia or during whole-body heating. Sweat rate was similarly unaffected by changes in arterial blood pressure during the heat stress. The lack of decrease in SSNA and sweat rate during pharmacologically induced changes in blood pressure suggests that arterial baroreceptors (i.e. carotid and aortic baroreceptors) are not involved in the regulation of these variables, thereby leaving the possibility that cardiopulmonary baroreceptors are responsible for modulating these responses. Conversely, an alternative hypothesis may be that baroreceptors in general are incapable of altering SSNA and sweat rate regardless of the thermal condition.
| REFERENCES |
|---|
|
|
|---|
| BINI, G., HAGBARTH, K. E., HYNNINEN, P. & WALLIN, B. G. (1980). Thermoregulatory and rhythm-generating mechanisms governing the sudomotor and vasoconstrictor outflow in human cutaneous nerves. Journal of Physiology 306, 537-552 | [Abstract] |
| BINI, G., HAGBARTH, K. E. & WALLIN, B. G. (1981). Cardiac rhythmicity of skin sympathetic activity recorded from peripheral nerves in man. Journal of the Autonomic Nervous System 4, 17-24 | [Medline] |
| BIRKETT, C. L., RAY, C. A., ANDERSON, E. A. & REA, R. F. (1992). A signal-averaging technique for the analysis of human muscle sympathetic nerve activity. Journal of Applied Physiology 73, 376-378 | [Medline] |
| CRANDALL, C. G., JOHNSON, J. M., KOSIBA, W. A. & KELLOGG, D. L. JR (1996). Baroreceptor control of the cutaneous active vasodilator system. Journal of Applied Physiology 81, 2192-2198 | [Abstract/Full Text] |
| CRANDALL, C. G., LEVINE, B. D. & ETZEL, R. A. (1999). Effect of increasing central venous pressure during passive heating on skin blood flow. Journal of Applied Physiology 86, 605-610 | [Abstract/Full Text] |
| DELIUS, W., HAGBARTH, K. E., HONGELL, A. & WALLIN, B. G. (1972a). Manoeuvres affecting sympathetic outflow in human muscle nerves. Acta Physiologica Scandinavica 84, 82-94 | [Medline] |
| DELIUS, W., HAGBARTH, K. E., HONGELL, A. & WALLIN, B. G. (1972b). Manoeuvres affecting sympathetic outflow in human skin nerves. Acta Physiologica Scandinavica 84, 177-186 | [Medline] |
| DIBNER-DUNLAP, M. E., SMITH, M. L., KINUGAWA, T. & THAMES, M. D. (1996). Enalapritlat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. Journal of the American College of Cardiology 27, 358-364 | [Medline] |
| DODT, C., GUNNARSSON, T., ELAM, M., KARLSSON, T. & WALLIN, B. G. (1995). Central blood volume influences sympathetic sudomotor nerve traffic in warm humans. Acta Physiologica Scandinavica 155, 41-51 | [Medline] |
| DU BOIS, D. & DU BOIS, E. F. (1916). Clinical calorimetry: A formula to estimate the approximate surface area if height and weight are known. Archives of Internal Medicine 17, 863-871 | |
| EBERT, T. J. & COWLEY, A. W. JR (1992). Baroreflex modulation of sympathetic outflow during physiological increases of vasopressin in humans. American Journal of Physiology 262, H1372-1378 | [Medline] |
| HAGBARTH, K. E., HALLIN, R. G., HONGELL, A., TOREBJORK, H. E. & WALLIN, B. G. (1972). General characteristics of sympathetic activity in human skin nerves. Acta Physiologica Scandinavica 84, 164-176 | [Medline] |
| JANIG, W. & KUMMEL, H. (1981). Organization of the sympathetic innervation supplying the hairless skin of the cat's paw. Journal of the Autonomic Nervous System 3, 215-230 | [Medline] |
| JOHNSON, J. M., NIEDERBERGER, M., ROWELL, L. B., EISMAN, M. M. & BRENGELMANN, G. L. (1973). Competition between cutaneous vasodilator and vasoconstrictor reflexes in man. Journal of Applied Physiology 35, 798-803 | [Medline] |
| JOHNSON, J. M. & PROPPE, D. W. (1996). Cardiovascular adjustments to heat stress. In Handbook of Physiology, section 4, Environmental Physiology, vol. I, ed. FREGLY, M. J. & BLATTEIS, C. M., pp. 215-243. Oxford University Press, New York | |
| KELLOGG, D. L., JOHNSON, J. M. & KOSIBA, W. A. (1990). Baroreflex control of the cutaneous active vasodilator system in humans. Circulation Research 66, 1420-1426 | [Abstract] |
| MACEFIELD, V. G. & WALLIN, B. G. (1996). The discharge behaviour of single sympathetic neurones supplying human sweat glands. Journal of the Autonomic Nervous System 61, 277-286 | [Medline] |
| MACK, G., NISHIYASU, T. & SHI, X. (1995). Baroreceptor modulation of cutaneous vasodilator and sudomotor responses to thermal stress in humans. Journal of Physiology 483, 537-547 | [Abstract] |
| MANCIA, G. & MARK, A. L. (1983). Arterial baroreflexes in humans. In Handbook of Physiology, section 2, The Cardiovascular System, vol. III, Peripheral Circulation and Organ Blood Flow, ed. SHEPHERD, J. T. & ABBOUD, F. M., pp. 755-793. American Physiological Society, Bethesda, MD, USA | |
| NORMELL, L. A. & WALLIN, B. G. (1974). Sympathetic skin nerve activity and skin temperature changes in man. Acta Physiologica Scandinavica 91, 417-426 | [Medline] |
| ROWELL, L. B. (1983). Cardiovascular aspects of human thermoregulation. Circulation Research 52, 367-379 | [Medline] |
| ROWELL, L. B., WYSS, C. R. & BRENGELMANN, G. L. (1973). Sustained human skin and muscle vasoconstriction with reduced baroreceptor activity. Journal of Applied Physiology 34, 639-643 | [Medline] |
| RUDAS, L., CROSSMAN, A. A., MORILLO, C. A., HALLIWILL, J. R., TAHVANAINEN, K. U., KUUSELA, T. A. & ECKBERG, D. L. (1999). Human sympathetic and vagal baroreflex responses to sequential nitroprusside and phenylephrine. American Journal of Physiology 276, H1691-1698 | [Medline] |
| SOLACK, S. D., BRENGELMANN, G. L. & FREUND, P. R. (1985). Sweat rate vs. forearm blood flow during lower body negative pressure. Journal of Applied Physiology 58, 1546-1552 | [Medline] |
| TAYLOR, W. F., JOHNSON, J. M., KOSIBA, W. A. & KWAN, C. M. (1989). Cutaneous vascular responses to isometric handgrip exercise. Journal of Applied Physiology 66, 1586-1592 | [Medline] |
| TRIPATHI, A. & NADEL, E. R. (1986). Forearm skin and muscle vasoconstriction during lower body negative pressure. Journal of Applied Physiology 60, 1535-1541 | [Medline] |
| VALLBO, A. B., HAGBARTH, K. E., TOREBJORK, H. E. & WALLIN, B. G. (1979). Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiological Reviews 59, 919-957 | [Medline] |
| VISSING, S. F. (2000). Neural control of skin circulation. In Exercise and Circulation in Health and Disease, ed. SALTIN, B., BOUSHEL, R., SECHER, N. & MITCHELL, J. H., pp. 103-111. Human Kinetics, Champaign, IL, USA | |
| VISSING, S. F., SCHERRER, U. & VICTOR, R. G. (1994). Increase of sympathetic discharge to skeletal muscle but not to skin during mild lower body negative pressure in humans. Journal of Physiology 481, 233-241 | [Abstract] |
| WALLIN, B. G., SUNDLOF, G. & DELIUS, W. (1975). The effect of carotid sinus nerve stimulation on muscle and skin nerve sympathetic activity in man. Pflügers Archiv 358, 101-110 | [Medline] |
Acknowledgements
The authors would like to express their appreciation to Dr Benjamin D. Levine and Robyn Etzel for their medical support, to Dr Manabu Shibasaki for his helpful comments and suggestions, and to the subjects for their willing participation in this project. This research project was funded in part by grants from the National Aeronautics and Space Administration (NAG9-1033) and the National Institutes of Health - National Heart, Lung, and Blood Institute (HL-61388 and HL-10488).
Corresponding author
C. G. Crandall: Institute for Exercise and Environmental Medicine, Presbyterian Hospital of Dallas, 7232 Greenville Ave., Dallas, TX 75231, USA.
Email: craigcrandall{at}texashealth.org
This article has been cited by other articles:
![]() |
J. Stewart Commentary on Viewpoint: The human cutaneous circulation as a model of generalized microvascular function J Appl Physiol, July 1, 2008; 105(1): 384 - 384. [Full Text] [PDF] |
||||
![]() |
D. V. Menon, Z. Wang, P. J. Fadel, D. Arbique, D. Leonard, J.-L. Li, R. G. Victor, and W. Vongpatanasin Central Sympatholysis as a Novel Countermeasure for Cocaine-Induced Sympathetic Activation and Vasoconstriction in Humans J. Am. Coll. Cardiol., August 14, 2007; 50(7): 626 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Keller, S. L. Davis, D. A. Low, M. Shibasaki, P. B. Raven, and C. G. Crandall Carotid baroreceptor stimulation alters cutaneous vascular conductance during whole-body heating in humans J. Physiol., December 15, 2006; 577(3): 925 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. McInnis, W. S. Journeay, O. Jay, E. Leclair, and G. P. Kenny 15{degrees} Head-down tilt attenuates the postexercise reduction in cutaneous vascular conductance and sweating and decreases esophageal temperature recovery time J Appl Physiol, September 1, 2006; 101(3): 840 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shibasaki, T. E. Wilson, and C. G. Crandall Neural control and mechanisms of eccrine sweating during heat stress and exercise J Appl Physiol, May 1, 2006; 100(5): 1692 - 1701. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cui, M. Sathishkumar, T. E. Wilson, M. Shibasaki, S. L. Davis, and C. G. Crandall Spectral characteristics of skin sympathetic nerve activity in heat-stressed humans Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1601 - H1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Wilson, D. J. Dyckman, and C. A. Ray Determinants of skin sympathetic nerve responses to isometric exercise J Appl Physiol, March 1, 2006; 100(3): 1043 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cui, A. Arbab-Zadeh, A. Prasad, S. Durand, B. D. Levine, and C. G. Crandall Effects of Heat Stress on Thermoregulatory Responses in Congestive Heart Failure Patients Circulation, October 11, 2005; 112(15): 2286 - 2292. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ichinose, K. Okazaki, S. Masuki, H. Mitono, M. Chen, H. Endoh, and H. Nose Ten-day endurance training attenuates the hyperosmotic suppression of cutaneous vasodilation during exercise but not sweating J Appl Physiol, July 1, 2005; 99(1): 237 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Wilson, J. Cui, and C. G. Crandall Mean body temperature does not modulate eccrine sweat rate during upright tilt J Appl Physiol, April 1, 2005; 98(4): 1207 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Keller, S. Ogoh, S. Greene, A Olivencia-Yurvati, and P. B Raven Inhibition of KATP channel activity augments baroreflex-mediated vasoconstriction in exercising human skeletal muscle J. Physiol., November 15, 2004; 561(1): 273 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Wilson, N. T. Kuipers, E. A. McHugh, and C. A. Ray Vestibular activation does not influence skin sympathetic nerve responses during whole body heating J Appl Physiol, August 1, 2004; 97(2): 540 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Ray and T. E. Wilson Comparison of skin sympathetic nerve responses to isometric arm and leg exercise J Appl Physiol, July 1, 2004; 97(1): 160 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shibasaki, M. Sakai, M. Oda, and C. G. Crandall Muscle mechanoreceptor modulation of sweat rate during recovery from moderate exercise J Appl Physiol, June 1, 2004; 96(6): 2115 - 2119. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Journeay, F. D. Reardon, C. R. Martin, and G. P. Kenny Control of cutaneous vascular conductance and sweating during recovery from dynamic exercise in humans J Appl Physiol, June 1, 2004; 96(6): 2207 - 2212. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Wilson, R. Carter III, M. J. Cutler, J. Cui, M. L. Smith, and C. G. Crandall Active recovery attenuates the fall in sweat rate but not cutaneous vascular conductance after supine exercise J Appl Physiol, February 1, 2004; 96(2): 668 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Kenny, J. Periard, W. S. Journeay, R. J. Sigal, and F. D. Reardon Effect of exercise intensity on the postexercise sweating threshold J Appl Physiol, December 1, 2003; 95(6): 2355 - 2360. [Abstract] [Full Text] |
||||
![]() |
D. N. Jackson and G. P. Kenny Upright LBPP application attenuates elevated postexercise resting thresholds for cutaneous vasodilation and sweating J Appl Physiol, July 1, 2003; 95(1): 121 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Carter III, T. E. Wilson, D. E. Watenpaugh, M. L. Smith, and C. G. Crandall Effects of mode of exercise recovery on thermoregulatory and cardiovascular responses J Appl Physiol, December 1, 2002; 93(6): 1918 - 1924. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cui, T. E. Wilson, and C. G. Crandall Phenylephrine-induced elevations in arterial blood pressure are attenuated in heat-stressed humans Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2002; 283(5): R1221 - R1226. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Wilson, J. Cui, R. Zhang, S. Witkowski, and C. G. Crandall Skin cooling maintains cerebral blood flow velocity and orthostatic tolerance during tilting in heated humans J Appl Physiol, July 1, 2002; 93(1): 85 - 91. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |